Intercell: EU Invests € 30m in Research Program

Companies › Health Care ♦ Published: September 29, 2011; 14:26 ♦ (Vindobona)

The Austrian pharmaceutical company will receive co-funding for a collaborative research project from the European Union.

Intercell: EU Invests € 30m in Research Program / Picture: © Intercell

Intercell AG today announced that on 1 October 2011 the collaborative research program – Advanced Immunization Technologies (ADITEC) – will start in order to accelerate the development of novel and powerful immunization technologies for the next generation of human vaccines.  ADITEC is co-funded with € 30m by the European Commission to establish a robust platform for innovation…

or Log In

Fast News Search
Related News
Intercell Looking for Private Equity Shareholder (September 27, 2011)
Intercell Successfully Completes Vaccine Study in India (September 16, 2011)
Intercell: Restructuring Is Progressing (August 16, 2011)
Intercell Is Looking for Financial Investors (July 19, 2011)
Intercell: “We Will Stabilize Our Share Price” (June 21, 2011)
Intercell to Cut Jobs and Research Budget (June 8, 2011)
Read More
Intercell, Health Policy, Pharmaceutical Industry, Funding, R & D, EU European Union
Featured
See latest Vindobona Newsletter